Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Zoledronic acid improves bone mineral density in paediatric spinal cord injury.
Diagnostic accuracy of current sonographic criteria for the detection of outflow abnormalities in the internal jugular veins.
Partial deficiency of sphingosine-1-phosphate lyase confers protection in experimental autoimmune encephalomyelitis.
Prognostic risk estimates of patients with multiple sclerosis and their physicians: comparison to an online analytical risk counseling tool.
Prevalence and incidence of Multiple Sclerosis in Campobasso (Molise region chieftown, southern Italy).
Current role of chemotherapy and bone marrow transplantation in multiple sclerosis.
Bioconcentration, metabolism and neurotoxicity of the organophorous flame retardant 1,3-dichloro 2-propyl phosphate (TDCPP) to zebrafish.
Regression to the Mean and Predictors of MRI Disease Activity in RRMS Placebo Cohorts - Is There a Place for Baseline-to-Treatment Studies in MS?
Disambiguating the optic nerve from the surrounding cerebrospinal fluid: Application to MS-related atrophy.
Experimental demyelination and remyelination of murine spinal cord by focal injection of lysolecithin.
Epstein-Barr virus infection-Related hemophagocytic lymphohistiocytosis.
The potential of epigenetic therapies in neurodegenerative diseases.
The repair Schwann cell and its function in regenerating nerves.
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.
Modeling the course and outcomes of MS is statistical twaddle-No.
Induction of regulatory T cells in Th1-/Th17-driven experimental autoimmune encephalomyelitis by zinc administration.
[The possibility of using music therapy in neurology on the example of multiple sclerosis].
Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
Disconnection mechanism and regional cortical atrophy contribute to impaired processing of facial expressions and theory of mind in multiple sclerosis: a structural MRI study.
Cortical thickness at the time of the initial attack in two patients with paediatric relapsing-remitting multiple sclerosis.
Oral fingolimod to treat multiple sclerosis: see your cardiologist first.
Serum proteomics in multiple sclerosis disease progression.
Natalizumab (TYSABRI) and multiple sclerosis. With longer follow-up: even more toxic than suspected.
Comment on "Fingolimod effects on left ventricular function in multiple sclerosis" Mult Scler 2015.

Pages